Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFKB1 | P19838 | 1/20 | 0.53 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.53 |
| ▸ | RELA | Q04206 | 1/20 | 0.53 |
| ▸ | LTB4R | Q15722 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.49 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.49 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.49 |
| ▸ | OXER1 | Q8TDS5 | 3/20 | 0.45 |
| ▸ | FAAH | O00519 | 6/20 | 0.44 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | DEGS1 | O15121 | 1/20 | 0.38 |
| ▸ | ASAH2 | Q9NR71 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9607134 | 0.90 | NFKB1 (0.63) | NFKB1NFKB2RELALTB4RALDH1A1 | |
| SCHEMBL9607099 | 0.88 | FFAR1 (0.56) | NFKB1NFKB2RELALTB4RALDH1A1 | |
| SCHEMBL9607098 | 0.85 | NFKB1 (0.62) | NFKB1NFKB2RELALTB4RALDH1A1 | |
| SCHEMBL9607095 | 0.83 | OXER1 (0.57) | NFKB1NFKB2RELALTB4RALDH1A1 | |
| SCHEMBL9607096 | 0.83 | FFAR1 (0.70) | NFKB1NFKB2RELALTB4RALDH1A1 | |
| SCHEMBL9607153 | 0.80 | NFKB1 (0.66) | NFKB1NFKB2RELALTB4RALDH1A1 | |
| SCHEMBL9607135 | 0.78 | FFAR1 (0.67) | NFKB1NFKB2RELALTB4RALDH1A1 | |
| SCHEMBL19651148 | 0.76 | FFAR1 (0.57) | NFKB1NFKB2RELAFFAR1FFAR4 | |
| SCHEMBL13352197 | 0.74 | FFAR1 (0.78) | NFKB1NFKB2RELAFFAR1FFAR4 | |
| SCHEMBL20039910 | 0.74 | FFAR1 (0.78) | NFKB1NFKB2RELAFFAR1FFAR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10006925-B2 | Methods and systems for metabolite and/or lipid-based detection of colorectal cancer and/or adenomatous polyps | Universal Diagnostics, S. L. (ES) | 2018-06-26 | — | — | US | disclosed |
| US-20170343567-A1 | METHODS AND SYSTEMS FOR METABOLITE AND/OR LIPID-BASED DETECTION OF COLORECTAL CANCER AND/OR ADENOMATOUS POLYPS | Universal Diagnostics, S.A. (ES) | 2017-11-30 | — | — | US | disclosed |
| US-20120136057-A1 | HYDROXY FATTY ACID COMPOUNDS AND USES THEREOF FOR DISEASE TREATMENT AND DIAGNOSIS | PHENOMENOME DISCOVERIES INC. (CA) | 2012-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120136057-A1 | HYDROXY FATTY ACID COMPOUNDS AND USES THEREOF FOR DISEASE TREATMENT AND DIAGNOSIS | HCAR2, ALOX5, ALOX12 | NFKB1 514/4885NFKB2 245/4885RELA 240/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.